Congress Returns: Funding Deadlines, Epstein Files, and Trump Tariffs

Congressional Priorities Upon Return

• 🗓️ Congress is back in session with a critical September 30th deadline to fund the government and avoid a shutdown.
• 🏛️ Lawmakers are also facing pressure regarding the Jeffrey Epstein files, with calls for their public release from both sides of the aisle.

Budgetary Disputes and Process Concerns

• ✂️ The White House's pocket rescission of $5 billion in foreign aid, following a previous $9.4 billion rescission package, has angered lawmakers.
• ⚖️ Concerns are raised that these actions undermine Congress's power of the purse, with some Republicans deeming the rescission unlawful.
• 📉 Democrats are looking to leverage the government funding process to potentially restore cuts made to Medicaid and SNAP in a recent Republican-led bill.

Forcing a Vote on Epstein Files

• 🗳️ Rep. Tom Massie (R-KY) plans to file a discharge petition to force a floor vote on the release of the Epstein files.
• 🤝 This bipartisan effort requires 218 signatures to bypass traditional legislative procedures and bring the issue to a vote.

Trump Tariffs and Supreme Court Appeal

• ⚖️ A federal appeals court struck down many of President Trump's tariffs, ruling that the administration overstepped its authority by using a national emergency justification.
• 📈 The ruling allowed tariffs to remain in place until mid-October, pending an appeal to the US Supreme Court, which will make the final decision.
• 🚫 This decision does not affect sector-specific tariffs like those on steel and aluminum.

CDC Leadership and Health Policy Concerns

• ⚠️ Nine former CDC directors have criticized Health Secretary Robert F. Kennedy Jr. in an op-ed, citing concerns about staffing cuts and unpreparedness for health emergencies.
• 🔬 They accuse Kennedy of replacing CDC experts with unqualified individuals and corrupting the scientific process for data review and committee meetings.
• 🗣️ Secretary Kennedy is set to face questions on Capitol Hill regarding these issues, with a hearing scheduled for Thursday.
• 💉 Recommendations on the COVID vaccine are also expected to be discussed, with President Trump demanding pharmaceutical companies release data.